Transcatheter Systems Inc

Combining materials advances with WW design patent, TSI addresses an unmet need in a fast growing market valued at $600 million

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Minneapolis, MN, US
  • Currency USD
  • Founded December 2017
  • Employees 2
  • Incorporation Type C-corp
  • Website http://under construction

Company Summary

Transcatheter Valve replacements, a paradigm changing medical procedures is growing at an astonishing rate due to technological advances and FDA clearances.
TSI, using a newly approved medical polymer that addresses every deficiecy noted on competing devices is developing a large bore vascular closure. Access site bleeding after a procedure is common complication that can increase mortality and cost as much as $39,000 per episode is the problem

Team

  • Gervaise Wilhelm
    CEO

    Officer and founder of six previous life science or medical device companies. All with the exception of one were cardiovascular related. As founder she raised initial money and maintained investor relations, recruited engingeering and clinical and regualtory staff, Medical advisory and scientific advisory groups, board members and legal and acccounting services

Advisors

  • Peter Fitzgerald MD PhD
    Unconfirmed
    David Holmes Jr MD
    Unconfirmed
    Matthew Becker PhD
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free